文献速递生殖医学

精子组蛋白保留表观基因组改变与不明原因男性因素不育及供卵体外受精周期中囊胚发育不良相关

Alterations in the sperm histone-retained epigenome are associated with unexplained male factor infertility and poor blastocyst development in donor oocyte IVF cycles.
PubMed 文献 · Hum Reprod · 2017-01-01

研究利用供卵体外受精周期中正常精液参数患者的精子(n=40)和囊胚(n=48),按囊胚发育分为良好组与不良组,比较精子DNA甲基化与miRNA谱。发现两组间1634个CpG位点甲基化存在显著差异(P<0.05),不良组整体甲基化降低且10个精子miRNA显著改变(P<0.05),与囊胚靶基因mRNA表达相关。

要点

  • 良好组精子组蛋白保留CpG岛呈高甲基化,不良组呈小而显著的甲基化降低(P<0.05)。
  • 不良组中胚胎发育相关基因的组蛋白保留CpG位点甲基化降低(P<0.05)。
  • 10个精子miRNA显著改变(P<0.05),与不良组囊胚靶基因mRNA表达改变相关(P<0.05)。

核心结论

  • 正常精液参数患者精子DNA甲基化模式和miRNA谱显著改变可导致囊胚发育不良,反映不明原因男性因素不育的一个亚群。

研究设计与样本

  • 研究纳入供卵体外受精周期中正常精液参数患者的精子样本(n=40)和囊胚(n=48),排除已知女性与男性不育因素。
  • 样本按囊胚发育分为良好组(第5天AA级囊胚≥20%且第5、6天可移植质量胚胎≥60%)与不良组(第5天AA级囊胚≤10%且第5、6天可移植质量胚胎≤40%)。

主要发现

  • 在组蛋白保留CpG岛区域鉴定出1634个CpG位点,两组间精子DNA甲基化存在显著差异(P<0.05)。
  • 良好组呈现 largely 高甲基化谱,不良组观察到小幅但 distinct 且统计学显著的偏移(P<0.05)。
  • 不良组中胚胎发育相关基因的组蛋白保留CpG位点甲基化降低(P<0.05)。
  • 10个精子miRNA显著改变(P<0.05),与不良组囊胚中靶基因mRNA表达改变相关(P<0.05)。

临床怎么用

  • 作者认为精子表观遗传轻微改变可能对生育力与胚胎发育能力有累积效应。
  • 作者指出精子表观遗传学与遗传知识对后代有重要意义,并为不明原因男性因素不育的潜在原因提供证据。

局限性

  • 对仅限于保留组蛋白的CpG岛区域检查仅代表精子表观基因组的一小部分。
  • 观察结果为描述性,需进一步研究阐明精子DNA甲基化差异对不明原因男性因素不育和囊胚发育的功能影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Is there a distinct sperm histone-retained epigenetic signature in unexplained male factor infertility patients resulting in compromised blastocyst development? SUMMARY ANSWER: Using only donor oocyte IVF cycles, sperm DNA methylation patterns and miRNA profiles were significantly altered in normozoospermic patients resulting in poor blastocyst development, reflecting a subset of unexplained male factor infertility. WHAT IS KNOWN ALREADY: Aberrant sperm DNA methylation has been associated with known male factor infertility, particularly noted in oligozoospermic patients. Unexplained male factor infertility remains a significant proportion of in vitro fertilization failures having unknown underlying physiology. STUDY DESIGN, SIZE, DURATION: Sperm samples (n = 40) and blastocysts (n = 48) were obtained during fertile donor oocyte IVF cycles with normozoospermic parameters, thereby excluding known female and male infertility factors. Samples were divided into two groups based on blastocyst development (Good Group = ≥20% embryos with D5 grade 'AA' blastocysts, and ≥60% embryos of transferable quality on D5 and D6; Poor Group = ≤10% embryos with D5 grade 'AA' blastocysts, and ≤40% embryos of transferable quality on D5 and D6). PARTICIPANTS/MATERIALS, SETTING, METHODS: Samples were obtained from patients undergoing IVF treatments with informed consent and institutional review board approval. The Infinium HumanMethylation450 BeadChip microarray was used to identify histone-retained CpG island genes and genomic regions showing differences in sperm DNA methylation between the Good Group and the Poor Group. Pathway and gene network analysis for the significantly altered genes was performed, and targeted DNA methylation validation was completed for 23 genes and two imprinting control regions. Sperm miRNA profiles were assessed using the TaqMan® Human MicroRNA Array Card, with corresponding blastocyst mRNA gene expression examined by qRT-PCR. MAIN RESULTS AND THE ROLE OF CHANCE: Our study is the first to investigate unexplained male factor infertility while significantly eliminating confounding female factors from our sample population by using only young fertile donor oocytes. We identified 1634 CpG sites located at retained histone CpG island regions that had significant sperm DNA methylation differentials between the two embryogenesis groups (P < 0.05). A largely hypermethylated profile was evident in the Good Group, with a small but distinct and statistically significant shift (P < 0.05) observed in the Poor Group. Genes involved in embryonic development were highly represented among histone-retained CpG sites with decreased methylation in the Poor Group (P < 0.05). Ten significantly altered sperm miRNAs (P < 0.05), correlated with altered target gene mRNA expression in the blastocysts from the Poor Group (P < 0.05). Taken together, significantly impacted sperm miRNA and target transcript levels in blastocysts from the Poor Group may contribute alongside aberrant sperm DNA methylation to the compromised blastocyst development observed. LIMITATIONS, REASONS FOR CAUTION: Our examination of CpG island regions restricted to retained histones represents only a small part of the sperm epigenome. The results observed are descriptive and further studies are needed to elucidate the functional effects of differential sperm DNA methylation on unexplained male factor infertility and blastocyst development. WIDER IMPLICATIONS OF THE FINDINGS: Slight epigenetic changes in sperm may have a cumulative effect on fertility and embryonic developmental competence. Knowledge of sperm epigenetics and inheritance has important implications for future generations, while providing evidence for potential causes of unexplained male factor infertility. STUDY FUNDING/COMPETING INTEREST(S): No external funding was used for this study. None of the authors have any competing interest.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Denomme MM, McCallie BR, Parks JC, et al. Alterations in the sperm histone-retained epigenome are associated with unexplained male factor infertility and poor blastocyst development in donor oocyte IVF cycles. Hum Reprod. 2017. PMID: 29087470. doi:10.1093/humrep/dex317

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。